Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...

Guidance to Reflect Transaction; Maintains Outlook for Remaining Businesses BATESVILLE, Ind., Feb. 5, 2025 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: ...

Despite revenue declines, Hillenbrand Inc (HI) focuses on strategic divestitures and strong aftermarket performance to drive ...

Robert VanHimbergen; Chief Financial Officer, Senior Vice President; Hillenbrand Inc ...

The central bank responded to a troubling mix of stuttering economic growth, stubborn inflation and President Trump's tariff threats. The efficiency gains of DeepSeek's AI models startled the power ...

U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private ...

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.